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We have previously shown that endocannabinoids promote sebaceous lipogenesis, and 
sebocytes are involved in the metabolism of the “endocannabinoid-like” substance 
oleoylethanolamide (OEA). OEA is an endogenous activator of GPR119, a recently de-
orphanized receptor, which is currently being investigated as a promising anti-diabetic 
drug target. Thus, in the current study, we investigated the effects of OEA as well as the 
expression and role of GPR119 in human sebocytes. 
We found that OEA promoted differentiation of human SZ95 sebocytes (elevated 
lipogenesis, enhanced granulation, and the induction of early apoptotic events), and it 
switched the cells to a pro-inflammatory phenotype (increased expression and release of 
several pro-inflammatory cytokines). Moreover, we could also demonstrate that 
GPR119 was expressed in human sebocytes, and its siRNA-mediated gene silencing 
suppressed OEA-induced sebaceous lipogenesis, which was mediated via JNK, 
ERK1/2, Akt/PKB, and CREB activation. Finally, our pilot data demonstrated that 
GPR119 was down-regulated in sebaceous glands of acne patients, arguing that 
GPR119 signaling may indeed be disturbed in acne. 
Collectively, our findings introduce the OEA!GPR119 signaling as a positive 
regulator of sebocyte differentiation, and highlight the possibility that dysregulation of 





The endocannabinoid system (ECS) is a multifaceted signaling network comprising 
endogenous ligands (“endocannabinoids” [eCBs]), receptors (e.g. CB1, CB2, etc.), and a 
complex enzyme and transport apparatus involved in synthesizing and degrading the 
eCBs. It regulates several aspects of the homeostasis, including e.g. appetite, lipid 
accumulation in adipocytes or immune responses (Maccarrone et al. 2015; Oláh et al. 
2017b; Solymosi and Köfalvi 2017; Tóth et al. 2019). Moreover, the complex 
cannabinoid signaling is deeply involved in the regulation of cutaneous physiology as 
well (Bíró et al. 2009; Maccarrone et al. 2015; Oláh and Bíró 2017; Tóth et al. 2019). 
 
GPR119, a recently de-orphanized “ECS-related” metabotropic receptor, has lately 
emerged as a promising therapeutic target in type 2 diabetes mellitus (T2DM) 
(Tyurenkov et al. 2017). Thus, from the point of view of the potential side effects it 
would be highly desirable to explore extrapancreatic expression of GPR119 in human 
tissues. According to an early study, GPR119 is expressed at the mRNA level in 
cultured primary human melanocytes (Scott et al. 2006), and was found to be 
overexpressed in melanomas as compared to nevi (Haskó et al. 2014; Qin et al. 2011). 
Intriguingly, however, apart from this, only scant evidence is available on this matter 
(Alexander 2016). 
 
We have previously shown that several members of the ECS are expressed in human 
sebaceous glands (SG), and that ECS regulates biology of the human sebocytes 
(Dobrosi et al. 2008; Oláh and Bíró 2017; Zákány et al. 2018). Indeed, we found that 
the locally produced prototypic eCBs (i.e. anandamide [AEA] and 2-
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arachidonoylglycerol [2-AG]) contributed to the maintenance of the homeostatic 
sebaceous lipogenesis via activating CB2 cannabinoid receptor and the ERK1/2 MAPK 
cascade (Dobrosi et al. 2008). We could also demonstrate that human sebocytes express 
all the key enzymes involved in the synthesis (e.g. N-acyl-ethanolamine specific 
phospholipase D [NAPE-PLD], etc.) and degradation (e.g. fatty acid amide hydrolase 
[FAAH]) of the major eCBs. Moreover, elevation of the eCB tone by pharmacological 
inhibition of the eCB membrane transporter promoted sebaceous lipogenesis, and 
resulted in anti-inflammatory effects (Zákány et al. 2018). Intriguingly, however, in 
contrast to the “classical” eCB signaling, activation of multiple ionotropic cannabinoid 
receptors belonging to the transient receptor potential (TRP) channel superfamily 
(namely TRPV1, TRPV3, and TRPV4) suppressed sebaceous lipogenesis (Oláh et al. 
2014; Szántó et al. 2019; Tóth et al. 2009), and induced a pro-inflammatory response 
(TRPV3) (Szántó et al. 2019), whereas plant-derived cannabinoids were proven to exert 
differential effects on human sebocytes (Oláh et al. 2016b; Oláh et al. 2014). Besides, 
we have also demonstrated that sebocytes are involved in the metabolism of the “eCB-
like” substance oleoylethanolamide (OEA) (Zákány et al. 2018) the most important 
endogenous activator of GPR119 (Alexander 2016). These data raised the possibility 
that the major cellular target of OEA, i.e. the aforementioned GPR119, may also be 
expressed in human SGs (Zákány et al. 2018). Thus, in the current study, we aimed to 
challenge this hypothesis, and, in the regrettable lack of appropriate animal model 
systems, investigated human SZ95 sebocytes, a widely accepted model system to study 
human SG biology (Szöllősi et al. 2017; Tóth et al. 2011; Zouboulis et al. 2014; 





OEA Promotes Differentiation Of Human Sebocytes 
“Classical” eCBs (i.e. AEA and 2-AG) as well as arachidonic acid (AA) typically 
promote sebaceous lipogenesis of SZ95 sebocytes at 30-50 µM in course of 24-48-hr 
treatments (Dobrosi et al. 2008; Géczy et al. 2012; Markovics et al. 2019; Oláh et al. 
2016b; Oláh et al. 2014; Szántó et al. 2019; Tóth et al. 2009; Zákány et al. 2018). Thus, 
first, we tested the effects of OEA at the 10 nM – 50 µM concentration range. We 
showed that, although up to 50 µM the endogenous GPR119 activator OEA did not 
influence viability (MTT-assay; Supplementary Figure S1a-b), or proliferation of 
SZ95 sebocytes (CyQUANT-assay; Supplementary Figure S2), it concentration-
dependently (1-50 µM) and significantly increased sebaceous lipogenesis (24- and 48-hr 
treatments; Nile Red; Figure 1a-b), and it also enhanced granulation of sebocytes (48-
hr treatments; flow cytometry – side scatter; Figure 1c). These data suggested that, 
similar to the “classical” eCBs (Dobrosi et al. 2008; Zákány et al. 2018), OEA is also 
able to promote differentiation of human sebocytes. Notably, lipogenic potential of 
OEA was comparable to the ones typically seen in case of “classical” eCBs (e.g. AEA 
[30 µM]), AA (50 µM), or the combination of linoleic acid and testosterone (LA+T; 100 
µM + 1 µM, respectively) (Dobrosi et al. 2008; Géczy et al. 2012; Makrantonaki and 
Zouboulis 2007; Markovics et al. 2019; Oláh et al. 2016b; Oláh et al. 2014; Szántó et al. 
2019; Tóth et al. 2009; Zákány et al. 2018) (48-hr treatments; Figure 1d). 
 
Since, besides the enhanced granulation and elevated sebaceous lipogenesis, 
programmed cell death is also a hallmark of this process (Zouboulis et al. 2014), next, 
we asked if OEA influences the ratio of apoptotic or necrotic cells. We found that 48-hr 
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OEA treatment led to a small, but significant decrease of the mitochondrial membrane 
potential, indicating the onset of early apoptotic processes, whereas the ratio of necrotic 
cells remained unchanged (Figure 1e). This suggests that OEA is indeed likely to 
induce differentiation of human sebocytes. 
 
OEA Induces Pro-Inflammatory Response In Human Sebocytes 
To further dissect how OEA influences sebocyte biology, we tested its effects on the 
immune behavior of these cells. We found that administration of OEA (50 µM; 3 hrs) 
induced a significant up-regulation of several key pro-inflammatory cytokines 
(interleukin [IL]-1α, IL-1β, IL-6, IL-8; Q-PCR), and increased the release of IL-6 and 
IL-8 (ELISA) (Figure 2a-f). Although the above effects were inferior to the ones of the 
pro-inflammatory positive control Toll-like receptor 4 activator lipopolysaccharide 
(Figure 2a-f), our data indicate that, besides promoting differentiation, administration 
of OEA results in a rather pro-inflammatory sebocyte phenotype. 
 
Lipogenic Effect Of OEA Is Not Mediated Via PPARα 
Next, we assessed the mechanism of the above differentiation-promoting effects. 
PPARs are central orchestrators of lipid synthesis, and are expressed in human 
sebocytes as well (Zouboulis et al. 2014). Since OEA is known to be able to activate 
PPARα (Fu et al. 2003), next, we investigated if this nuclear receptor is involved in 
mediating its lipogenic action. Of great importance, we found that, although it tended to 
suppress it, the selective PPARα antagonist GW 7461 (1 µM) had no significant effect 
on the OEA-induced lipogenesis (48-hr treatments; Figure 3a), making PPARα an 




Human Sebocytes Express GPR119 Both In Vitro And In Situ 
Considering that not only PPARα, but also GPR119 was described to mediate cellular 
effects of OEA, next we investigated if this receptor is expressed in human sebaceous 
glands. We showed that GPR119 was expressed in human sebocytes both at the mRNA 
(Q-PCR) and protein levels (Western blot) (Figure 3b-c). Moreover, we also confirmed 
the presence of the receptor in human SGs in situ (immunohistochemistry; Figure 3d; 
appropriate positive control staining of pancreas is presented on Supplementary 
Figure S3). Having evidenced the presence of GPR119, next we assessed its role in 
regulating SG biology. 
 
Lipogenic Effect Of OEA Is Suppressed By GPR119 Silencing 
In the lack of selective antagonists (Alexander 2016), we turned to a molecular biology 
approach, i.e. siRNA-mediated selective gene silencing. Of great importance, we found 
that silencing (validated by Q-PCR and Western blot; Figure 3e-f) of GPR119 
expression significantly suppressed lipogenic action of OEA (Figure 3g), confirming 
that it was indeed a mostly GPR119-mediated effect; however, involvement of the 
activation of putative GPR119-independent lipogenic pathways cannot be excluded. 
 
Since receptor-mediated actions usually exhibit saturation kinetics, at this point we also 
tested the effects of higher OEA concentrations (100, 300, and 500 µM) on the lipid 
synthesis. We found that sebaceous lipogenesis could be further enhanced by 100 and 
300 µM of OEA, where it seemed to be saturated (no statistically significant difference 
could be observed between the lipogenic effect of 100 and 300 µM). However, OEA 
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was clearly cytotoxic at 500 µM thereby resulting in an artificially low lipid level (24-hr 
treatments; Supplementary Figure S4a-b). 
 
Lipogenic Effect Of OEA Is Mediated Via The Activation Of Several Kinase 
Cascades 
Next, we assessed the effects of OEA on two important, ECS-relevant regulators of 
sebaceous lipogenesis, i.e. calcium homeostasis and ERK1/2 MAPK cascade (Dobrosi 
et al. 2008; Oláh et al. 2014). We found that acute OEA administration did not alter 
[Ca2+]IC (Fluo-4 AM-based fluorescent Ca2+-measurement; Supplementary Figure S5), 
but, similar to the “classical” eCBs (Dobrosi et al. 2008), it activated the ERK1/2 
MAPK pathway as revealed by the elevated level of phosphorylated (i.e. activated) 
ERK1/2 in the OEA-treated cells compared to the vehicle-treated control group (20 min 
treatments; Western blot; Figure 4a). Moreover, the ERK1/2 MAPK inhibitor PD 
98059 (10 µM), was able to significantly suppress the lipogenic effect of OEA (24-hr 
treatments; Figure 4b), confirming that activation of this pathway was indeed involved 
in mediating it. However, it should also be noted that, when applied alone, PD 98059 
suppressed basal sebaceous lipid synthesis as well (Figure 4b), indicating that this 
signaling pathway may also be involved in maintaining the homeostatic lipogenesis of 
human sebocytes. 
 
Considering that GPR119 usually, but not exclusively, exerts its biological effects as a 
Gs-coupled receptor (Hassing et al. 2016), we also assessed the effects of OEA on the 
intracellular cAMP level. We found that, although OEA (50 µM; 60 min) tended to 
increase cAMP level of human sebocytes, this elevation failed to reach statistical 
 
9 
significance (Figure 4c). Thus, in order to further dissect its mechanism of action, we 
turned to a medium-throughput screening method, and used the Proteome Profiler 
Human Phospho-Kinase Array Kit enabling the simultaneous investigation of several 
different kinase cascades and related proteins. 20 min treatment of sebocytes with OEA 
(50 µM) or vehicle revealed that multiple signaling pathways got activated upon OEA 
treatment, including known lipogenic pathways such as c-Jun N-terminal kinase (JNK)-
1/2/3 (Choi et al. 2012; Kwon et al. 2019) or Akt/protein kinase B (PKB) (Choi et al. 
2012; Smith et al. 2008), and other molecules (e.g. cAMP response element-binding 
protein [CREB], Signal Transducers and Activators of Transcription 5 [STAT5], etc.) 
(summarized in Table 1). Importantly, although it tended to suppress it, 
pharmacological blockade of STAT5 failed to significantly alter OEA-induced 
lipogenesis (48-hr treatments; Figure 4d), whereas inhibition of JNK, CREB, and 
Akt/PKB could abrogate lipogenic effect of OEA (48-hr treatments; Figure 4e). 
 
Taken together, the above data strongly argued that dysregulation of the homeostatic 
OEA!GPR119 signaling might contribute to the development of sebum overproducing 
sebaceous gland dysfunctions, e.g. seborrhea or acne, therefore, we decided to assess its 
expression within the confines of a pilot experiment in SGs of 6 acne patients as well as 
of 6 acne-free individuals (relevant anamnestic data of the donors are summarized in 
Supplementary Table S1). Of great importance, despite of the relatively low number 
of participants and the apparently high inter-donor variability, we found that GPR119 
expression exhibited a significant decrease in the SGs of acne patients (Figure 5a-c) 
arguing that homeostatic GPR119 signaling might indeed be disturbed in acne at least in 







In the current study, we present evidence demonstrating that i) OEA promotes 
differentiation of human sebocytes as revealed by elevated sebaceous lipogenesis and 
cellular granulation (Figure 1a-c); ii) it induces early apoptotic processes (Figure 1e); 
and iii) switches the sebocytes to a pro-inflammatory phenotype (Figure 2a-f). 
Importantly, although in case of the inhibition of the eCB membrane transporter, we 
found that moderate stimulation of sebaceous lipogenesis was accompanied by anti-
inflammatory actions (Zákány et al. 2018), coupling of lipogenesis and pro-
inflammatory response is not unprecedented. Indeed, we have previously shown that 
leptin promotes sebaceous lipogenesis and triggers a pro-inflammatory response in 
human sebocytes via activating STAT3 and the p65 NF-κB pathway (Törőcsik et al. 
2014). 
 
When further assessing the mechanism of action, we could also demonstrate that OEA 
influenced the activity of several second messenger pathways (Table 1). Its lipogenic 
action was independent of PPARα (Figure 3a), but could be partially suppressed by 
silencing of GPR119 (Figure 3b-g), as well as by inhibition of ERK1/2, JNK, 
Akt/PKB, and CREB, whereas pharmacological blockade of STAT5 (which is involved 
in regulating immune responses in the pilosebaceous unit (Legrand et al. 2016)) had no 
significant effect (Figure 4a-e). 
 
Importantly, although GPR119 usually mediates its actions in a Gs-protein-coupled 
manner via the elevation of the cAMP level, it is not unprecedented that it may activate 
alternative signaling pathways, and may exhibit significant signaling bias (Hassing et al. 
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2016). An obvious candidate mechanism for such actions could be the activation of the 
β-arrestin pathway, which is not only capable of desensitizing/down-regulating G-
protein-coupled receptors, but can also activate the ERK1/2 MAPK cascade 
(Pouysségur 2000). In line with this, in a recent study, effects of oleoyl-
lysophosphatidylinositol on glucagon-like peptide-1 secretion from L-cells were found 
to be mediated via GPR119, and the subsequent activation of ERK1/2 MAPK as well as 
the cAMP/PKA/CREB pathways (Arifin et al. 2018), whereas in another study, 
activation of GPR119 was followed by cAMP accumulation, Ca2+-signal, and ERK1/2 
MAPK activation (Zhang et al. 2014). Intriguingly, in our hands, OEA (50 µM) had no 
effect on the Ca2+-homeostasis of the sebocytes (acute treatment; Supplementary 
Figure S5), and only tended to elevate cAMP level of the sebocytes (60 min; Figure 
4c). On one hand, the latter might be explained by signaling bias and the activation of 
alternative second messenger systems. However, considering the well-known 
compartmentalization of cAMP signaling (Calebiro and Maiellaro 2014), this finding 
does not necessarily exclude the possibility that cAMP contributes to at least some 
effects of OEA, since we only tested cAMP levels in whole cell lysates, and did not 
investigate if cAMP level reaches statistically significant elevation in any subcellular 
microcompartments upon OEA-treatment. 
 
In line with this argument, activation of CREB (Table 1), pharmacological blockade of 
which was also successful in abrogating lipogenic effect of OEA (Figure 4e), is an 
indirect pointer indicating that cAMP may indeed play a role in mediating certain 
effects of OEA. However, it is important to emphasize that CREB activation can be 
achieved not only through the elevation of the cAMP level, but also via alternative 
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signaling pathways, including, but not limited to Akt/PKB (Du and Montminy 1998). 
Importantly, Akt/PKB (Choi et al. 2012; Smith et al. 2008), as well as JNK MAPK 
(Choi et al. 2012; Kwon et al. 2019) are known to mediate lipogenic actions of various 
mediators in human sebocytes. Moreover, the aforementioned OEA treatment (50 µM, 
20 min) was found to activate them (Table 1), and, as expected, their pharmacological 
inhibition could suppress OEA-induced sebaceous lipogenesis (Figure 4e). 
Furthermore, it should also be noted that Akt/PKB can phosphorylate and thereby 
inactivate glycogen synthase kinase-3α/β (GSK-3α/β), which leads to reduced 
ubiquitination and degradation of β-catenin (Beurel et al. 2015; Patel and Woodgett 
2017; Souder and Anderson 2019). Of great importance, our data obtained by the 
phosphokinase array are completely in line with this. Indeed, we found that OEA-
treatment led to the (inhibitory) S21/S9 phosphorylation of GSK-3α/β and to the 
elevation of β-catenin level (Table 1). Thus, these data indirectly argue that Akt/PKB is 
indeed activated upon OEA-treatment in human sebocytes.  
 
Intriguingly, however, according to our pilot data obtained by the comparison of 
GPR119 expression in 6 acne and 6 acne-free patients, GPR119 was down-regulated in 
sebaceous glands of acne patients (Figure 5a-c). Although because of the relatively low 
number of involved patients, as well as of the apparent inter-donor variability, it would 
be premature to draw bold conclusions, our data argue that GPR119 signaling may 
indeed be disturbed at least in a subset of acne patients. Importantly, activation-induced 
down-regulation/desensitization is a commonly known phenomenon in case of several 
G-protein coupled receptors (Abdullah et al. 2016; Billington and Penn 2003; Geppetti 
et al. 2015; Skieterska et al. 2017), including GPR119 (Hassing et al. 2016; Zhang et al. 
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2014). Thus, our data highlight the possibility that GPR119 (over)activation might be 
involved in the initiation phase rather than later stages of acne. Alternatively, it is also 
possible that down-regulation of the pro-lipogenic GPR119 receptor is a secondary 
compensatory mechanism, and represents a biological response to the already highly 
elevated, acnegenic sebum production. 
 
It is also important to note that the OEA concentrations used in this study may seem 
high in light of its usual plasma concentration (~4 nM) (Bachkangi et al. 2019). 
However, several lines of evidence argue that they are relevant. First, sebocytes express 
NAPE-PLD (i.e. a key enzyme involved in the synthesis of OEA (Igarashi et al. 2019)), 
therefore the local concentration of OEA may be higher than its serum level (Zákány et 
al. 2018). Second, according to the IUPHAR database, pEC50 value for OEA in case of 
GPR119 is 5.4–6.3 (i.e. ~500 nM–4 µM) (Alexander et al. 2019), which means that in 
order to fully activate GPR119, OEA definitely needs to be applied at the low 
micromolar range. Importantly, similar EC50 data (85 nM to 15 µM) were recently 
reported by Hassing et al. (Hassing et al. 2016), further underscoring the relevance of 
administering OEA at the micromolar range. Likewise, in another recent study, the 
authors used 5 mM 2-oleoylglycerol (2-OG) to activate GPR119, and to lower the 
intraocular pressure. According to their data obtained in GPR119-/- mice, the effects of 
this extremely high concentration of 2-OG were still mediated by GPR119 (Miller et al. 
2017). This, together with the fact that pEC50 of 2-OG is 5.6 according to the IUPHAR 
database, i.e. it is almost identical to the one of OEA, collectively argue that 
administration of 50 µM OEA can be justified. Moreover, one should also take into 
consideration that sebocytes were cultured in a serum containing medium, and hence, 
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plasma proteins of the medium certainly bind some fraction of OEA. Therefore, it is 
highly likely that the concentration of the active, free fraction of this lipophilic molecule 
was less than the ones administered. Finally, it should also be noted that “classical” 
eCBs (i.e. AEA and 2-AG) also promoted sebaceous lipogenesis and differentiation at 
the low micromolar range (i.e. at 30 µM) in a receptor-dependent manner (Dobrosi et al. 
2008). 
 
Collectively, our findings introduce the OEA!GPR119 signaling pathway as a 
previously unidentified, positive regulator of human sebaceous lipogenesis and sebocyte 
differentiation. Since beyond these effects, administration of OEA led to a pro-
inflammatory phenotype too, our data highlighted the possibility that dysregulation of 
the above signaling pathway may contribute to the development of acne, a disease 
characterized by increased sebaceous lipogenesis and inflammation (Zouboulis et al. 
2014). Further studies are therefore invited to explore if disturbed OEA and/or GPR119 
signaling play any role in seborrhea and/or acne, and if pharmacological blockade of 
GPR119 results in beneficial effects in these diseases. Finally, our data also warn of risk 
of potential cutaneous side effects (i.e. seborrhea and acne) upon clinical administration 





MATERIALS & METHODS 
Materials 
Oleoylethanolamide (OEA), arachidonoylethanolamine (anandamide [AEA]), as well as 
the STAT5-inhibitor (2-[(4-oxo-4H-1-benzopyran-3-yl)methylene]hydrazide 3-
pyridinecarboxylic acid; [STAT5i]) were purchased from Cayman Chemical Company 
(Ann Arbor, MI, USA); γ-irradiated lipopolysaccharide from Escherichia coli 026:B6 
(LPS), arachidonic acid (AA), linoleic acid (LA), and testosterone (T) were obtained 
from Sigma-Aldrich (St. Louis, MO, USA), PD 98059 (ERK1/2 MAPK-inhibitor (Qi et 
al. 2004)) from Calbiochem (Darmstadt, Germany), whereas SU 3327 (JNK-inhibitor 
(De et al. 2009)), GSK 690693 (Akt/PKB-inhibitor (Heerding et al. 2008)), compound 
666-15 (CREB-inhibitor (Xie et al. 2015)), and GW 6471 (PPARα-antagonist (Müller et 
al. 2009)) from Tocris (Bio-Techne R&D Systems, Minneapolis, MN, USA). OEA, 
AEA, LA, and AA were dissolved in absolute ethanol, whereas the solvent for PD 
98059, SU 3327, GSK 690693, compound 666-15, STAT5i, and T was dimethyl 
sulfoxide (DMSO). LPS was dissolved in filtered distilled water. 
 
Cell Culturing 
Human immortalized SZ95 sebocytes, originated from human facial sebaceous glands 
(Zouboulis et al., 1999), were cultured in Sebomed® Basal Medium (Biochrom, Berlin, 
Germany) supplemented with 10 (V/V)% fetal bovine serum (Gibco, ThermoFisher, 
Waltham, Massachusetts, USA), 1 mM CaCl2, 5 ng/ml human epidermal growth factor 
(Sigma-Aldrich), and MycoZap™ Plus-CL (1:500; Lonza, Basel, Switzerland). The 
medium was changed every other day, and cells were subcultured at 60-70% 
confluence. Cells were regularly checked for Mycoplasma contamination by using 
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Primary human material was collected after obtaining written informed consent, 
adhering to Helsinki Declaration, and after obtaining Institutional Research Ethics 
Committee’s and Government Office for Hajdú-Bihar County’s permission (document 
IDs: IX-R-052/01396-2/2012, IF-12817/2015, IF-1647/2016, IF-778-5/2017, DE 
RKEB/IKEB 4988-2018). 
 
Detailed description of the methods to assess sebaceous lipogenesis (Nile Red), 
differentiation-associated granulation (flow cytometry), viability (MTT-assay), cell 
death (DilC1(5)-SYTOX Green labeling), proliferation (CyQUANT-assay), Ca2+-
homeostasis (Fluo-4 AM-based fluorescent Ca2+-measurement), gene expression at the 
mRNA (Q-PCR) and protein levels (Western blot, immunohistochemistry, ELISA), and 
siRNA-mediated silencing can be found in our previous publications (Lisztes et al. 
2019; Markovics et al. 2019; Oláh et al. 2017a; Oláh et al. 2016a; Oláh et al. 2014; 
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Table 1 List of signaling molecules exhibiting relevant (≥1.3-fold) increase in 
phosphokinase array signal intensity following 20 min treatment with 50 µM OEA 
Signaling molecule Phosphorylation site Fold-change over vehicle control Abbreviation Full name 
JNK 1/2/3 c-Jun N-terminal kinase 1/2/3 
T183/Y185 (activating 
phosphorylation of 



































AKT 1/2/3 Protein kinase B S473 (activating phosphorylation) 1.46 






Figure 1 The GPR119 agonist OEA promotes sebaceous lipogenesis and induces 
differentiation of human sebocytes 
(a-b and d) Nile Red assays. Lipogenesis of SZ95 sebocytes was assessed following 24- 
(a) and 48-hr (b and d) treatments. Results are expressed in the percentage of the 
vehicle control (100%, solid line) as mean±SEM of four independent determinations. 
Two additional experiments yielded similar results. *, **, and *** mark significant 
(P<0.05, 0.01, and 0.001, respectively) differences compared to the respective vehicle 
treated control group. (c) Flow cytometry. Sebocytes were treated as indicated for 48 
hrs, and granularity was then measured by assessing side scatter. Right shift of the curve 
indicates increased granulation upon OEA treatment. (e) Combined fluorescent 
DilC1(5)-SYTOX Green labeling. To monitor apoptotic and necrotic cell death, SZ95 
sebocytes were treated as indicated for 48 hours. Results are expressed in the percentage 
of the vehicle control (100%, solid line; DilC1(5), apoptosis data) or in the percentage of 
the positive control (100%, solid line; SYTOX Green, necrosis data) as mean±SEM of 
four independent determinations. Two additional experiments yielded similar results. ** 
and *** mark significant (P<0.01 or P<0.001) differences compared to the respective 
(DilC1(5) or SYTOX Green) vehicle control groups. CCCP: carbonyl cyanide m-
chlorophenyl hydrazone (1:200; apoptosis positive control); LB: lysis buffer (1:100; 
positive control for necrosis); AA: arachidonic acid (50 µM); AEA: anandamide (30 




Figure 2 OEA increases expression and release of several pro-inflammatory cytokines 
(a-d) Q-PCR. IL-1α, IL-1β, IL-6, and IL-8 mRNA expression in human SZ95 sebocytes 
was determined following the indicated 3-hr treatments. Data are presented by using 
∆∆CT method regarding 18S RNA-normalized mRNA expressions of the vehicle 
control as 1. Data are expressed as mean±SD of 3 determinations. One additional 
experiment yielded similar results. ***P<0.001 compared to the control group. (e-f) 
ELISA. IL-6 and IL-8 content of the sebocyte supernatants was determined following 
the indicated 3-hr treatments. Data are expressed as mean±SEM of 2-3 determinations. 
One additional experiment yielded similar results. *, and *** mark significant (P<0.05, 
or 0.001, respectively) differences compared to the control group. LPS: 
lipopolysaccharide; OEA: oleoylethanolamide. 
 
Figure 3 Lipogenic effect of OEA is mediated via activation of GPR119, and is 
independent of PPARα 
(a) Nile Red assay. Lipogenesis of SZ95 sebocytes was assessed following 48-hr 
treatments. Results are expressed in the percentage of the vehicle control (100%, solid 
line) as mean±SEM of four independent determinations. Two additional experiments 
yielded similar results. *** marks significant (P<0.001) difference as indicated. n.s.: not 
significant. (b) Q-PCR. SZ95 sebocytes were harvested at different confluences. 
GPR119 expression was normalized to the level of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) of the same sample, and is expressed as mean±SD of three 
determinations. (c) Pre- and post-confluent sebocytes were harvested, and cell lysate 
was subjected to Western blot analysis to detect GPR119 expression at the protein level. 
(d) Immunohistochemistry. Specific immunopositivity was visualized by 3,3’-
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diaminobenzidine (DAB; brown color), whereas nuclei were counterstained by 
hematoxylin (blue color). Original magnification: 400x; scale bars: 50 µm. Negative 
control (bottom) was obtained by omitting the primary antibody. (e) GPR119 mRNA 
expression was down-regulated by GPR119 siRNA transfection (siGPR119). SZ95 
sebocytes were harvested on post-transfection day 2. GPR119 expression was detected 
by Q-PCR. GPR119 expression was first normalized to the expression level of 18S RNA 
of the same sample used as internal control, and relative mRNA expression was then 
normalized to the one of the non-sense RNA transfected scrambled (SCR) control 
group. Data are expressed as mean±SD of three determinations. (f) Western blot 
analyses of lysates of non-sense RNA transfected (SCR: scrambled control), and 
GPR119-silenced SZ95 sebocytes harvested on post-transfection Day 2. (g) Sebaceous 
lipogenesis assessed by Nile Red assay on SCR-transfected as well as GPR119-silenced 
sebocytes. 48-hr treatments were initiated on post-transfection Day 3. Results are 
expressed in the percentage of the SCR vehicle control (100%, solid line) as 
mean±SEM of four independent determinations. Two additional experiments yielded 
similar results. 
 
Figure 4 Lipogenic action of OEA is mediated via activating ERK1/2, JNK, and CREB, 
but is likely to be independent of STAT5 
(a) Western blot analysis of lysates of SZ95 sebocytes treated with OEA or vehicle for 
20 minutes. Two additional experiments yielded similar results. (b) Sebaceous 
lipogenesis assessed by Nile Red assay following the indicated 24-hr treatments. 
Results are expressed in the percentage of the vehicle control (100%, solid line) as 
mean±SEM of twelve independent determinations. (c) cAMP ELISA. Sebocytes were 
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treated for 60 min with OEA or vehicle. Data are presented as mean±SD of three 
determinations. n.s.: not significant, as indicated. (d-e) Nile Red assays. Lipogenesis of 
SZ95 sebocytes was assessed following 48-hr treatments. Results are expressed in the 
percentage of the vehicle control (100%, solid line) as mean±SEM of eight (d) or 
twelve (e) independent determinations. *** marks significant (P<0.001) difference as 
indicated. n.s.: not significant. 666-15: CREB-inhibitor; GSK 690693: Akt/PKB-
inhibitor; OD: normalized optical densities (control = 1). OEA: oleoylethanolamide; 
PD 89059: ERK1/2 MAPK inhibitor; STAT5i: STAT5-inhibitor; SU 3327: JNK-
inhibitor. 
 
Figure 5 GPR119 is down-regulated in sebaceous glands of acne patients 
(a-b) Representative immunohistochemistry images. Specific immunopositivity was 
visualized by 3,3’-diaminobenzidine (DAB; brown color), whereas nuclei were 
counterstained by hematoxylin (blue color). Original magnification: 200x; scale bars: 
100 µm. (c) Statistical analysis of GPR119 signal intensity obtained by semi-
quantitative image analysis (scatter plot superimposed with mean±SD of the donors). 
















SUPPLEMENTARY MATERIALS & METHODS 
Determination Of Intracellular Lipids 
For quantitative measurement of sebaceous (neutral) lipid content, SZ95 sebocytes 
(20,000 cells/well) were cultured in 96-well “black well/clear bottom” plates (Greiner 
Bio-One, Frickenhausen, Germany) in quadruplicates, and were treated with 
compounds as indicated. Subsequently, supernatants were discarded, cells were washed 
twice with phosphate-buffered saline (PBS; 115 mM NaCl, 20 mM Na2HPO4, pH 7.4; 
all from Sigma-Aldrich), and 100 µl of a 1 µg/ml Nile Red (Sigma-Aldrich) solution in 
PBS was added to each well. The plates were then incubated at 37°C for 30 min, and 
fluorescence was measured on FlexStation 3 multimode microplate reader (Molecular 
Devices, San Francisco, CA, USA). Results, measured in relative fluorescence units, are 
expressed as percentage of the vehicle control regarded as 100%, using 485 nm 
excitation and 565 nm emission wavelengths. 
 
Determination Of Cellular Viability 
The viability of SZ95 sebocytes was determined by MTT-assay (Sigma-Aldrich) 
measuring the conversion of the tetrazolium salt to formazan by mitochondrial 
dehydrogenases. Cells were plated in 96-well plates (20,000 cells/well) in 
quadruplicates, and were treated as indicated. Cells were then incubated with 0.5 mg/ml 
MTT reagent for 3 hrs, and concentration of formazan crystals (as an indicator of 
number of viable cells) was determined colorimetrically at 565 nm by using FlexStation 
3 multi-mode microplate reader (Molecular Devices). Results were expressed as 




Determination Of Apoptosis 
A decrease in the mitochondrial membrane potential is one of the earliest markers of 
apoptosis (Green and Reed, 1998, Susin et al. 1998). Therefore, to assess the process, 
mitochondrial membrane potential of SZ95 sebocytes was determined using a 
MitoProbe™ DilC1(5) Assay Kit (Invitrogen/ThermoFisher). Cells (20,000 cells/well) 
were cultured in 96-well “black well/clear bottom” plates (Greiner Bio-One) in 
quadruplicates and were treated as indicated. After removal of supernatants, cells were 
incubated for 30 minutes with DilC1(5) working solution (50 µl/well), then washed with 
PBS, and the fluorescence of DilC1(5) was measured at 630 nm excitation and 670 nm 
emission wavelengths using FlexStation 3 multi-mode microplate reader (Molecular 
Devices). Relative fluorescence values were expressed as percentage of vehicle control 
regarded as 100%. As a positive control for apoptosis, we applied carbonyl cyanide m-
chlorophenyl hydrazone (CCCP; Life Technologies Hungary Ltd.) dissolved in the 
DilC1(5) working solution (1:200 for 30 min at 37°C). 
 
Determination Of Necrosis 
Necrotic processes were determined by SYTOX Green staining (ThermoFisher). The 
dye is able to penetrate (and then to bind to the nucleic acids) only to necrotic cells with 
ruptured plasma membranes, whereas healthy cells with intact surface membranes show 
negligible SYTOX Green staining intensity. Cells were cultured in 96-well “black 
well/clear bottom” plates (Greiner Bio-One), and treated as indicated. Supernatants 
were then discarded, and SZ95 sebocytes were incubated for 30 minutes with 1 µM 
SYTOX Green dye. Following incubation, cells were washed with PBS, the culture 
medium was replaced, and fluorescence of SYTOX Green was measured at 490 nm 
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excitation and 520 nm emission wavelengths using FlexStation 3 multi-mode 
microplate reader (Molecular Devices). As a positive control for necrosis, lysis buffer 
(LB; 1:100 in the SYTOX Green working solution for 30 min at 37°C; Life 
Technologies Hungary Ltd.) was applied. Relative fluorescence values were expressed 
as percentage of positive control regarded as 100%. Due to their spectral properties, 
DilC1(5) and SYTOX Green dyes were always administered together, enabling us to 
investigate necrotic and early apoptotic processes of the same cultures. Selective 
decrease of DilC1(5) intensity indicated mitochondrial depolarization (i.e. the onset of 
early apoptotic processes), whereas increase of SYTOX Green staining intensity 
revealed necrotic cell death. 
 
Determination Of Cellular Proliferation 
The degree of cellular growth (reflecting proliferation) was determined by measuring 
the DNA content of cells using CyQUANT Cell Proliferation Assay Kit 
(Invitrogen/ThermoFisher). SZ95 sebocytes (2,000 cells per well) were cultured in 96-
well “black well/clear bottom” plates (Greiner Bio-One) and were treated as indicated. 
Supernatants were then removed by blotting on paper towels, and the plates were 
subsequently frozen at -80°C. The plates were then thawed at room temperature, and 
200 µl of CyQUANT dye/cell lysis buffer mixture was added to each well. After 5 min 
of incubation, fluorescence was measured at 490 nm excitation and 520 nm emission 
wavelengths using FlexStation 3 multimode microplate reader (Molecular Devices). 
Relative fluorescence values were expressed as percentage of 24-hr vehicle control 






SZ95 sebocytes were cultured in 6-well plates and treated with OEA or vehicle for 48 
hrs. Then, cells were scraped in PBS, and the suspension was homogenized by intense 
trituration. Finally, the cells were subjected to flow cytometry in a BD FACS Calibur 
(Franklin Lakes, NJ, USA). As a parameter reflecting cellular granulation, and hence 
differentiation, side scatter was detected, and data were analyzed using FlowJo (FlowJo 
LLC, Ashland, OR, USA) software. 
 
RNA Isolation, Reverse Transcription And Quantitative ‘Real-Time’ PCR (Q-
PCR) 
Q-PCR was performed on a Roche LightCycler 480 System (Roche, Basel, Switzerland) 
using the 5’ nuclease assay. Total RNA was isolated using TRIzol (Sigma-Aldrich), 
DNase treatment was performed according to the manufacturer’s protocol, and then, 1 
µg of total RNA was reverse-transcribed into cDNA using High-Capacity cDNA Kit 
from Ambion™ (Invitrogen, ThermoFisher). PCR amplification was performed using 
the TaqMan® Gene Expression Assays (assay IDs: Hs00174092_m1 for interleukin 
[IL]-1α, Hs00174097_m1 for IL-1β, Hs00985639_m1 for IL-6, Hs00174103_m1 for IL-
8, Hs02825719_s1 for GPR119) and the TaqMan universal PCR master mix protocol 
(Applied Biosystems). As internal controls, transcripts of 18S RNA (assay ID: 
Hs03928985_g1) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH; assay ID: 
Hs99999901_s1) were determined. The amount of the transcripts was normalized to 
those of the housekeeping gene using the ∆CT method. Finally, when indicated, the 
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relative expression values were further normalized to the ones of the vehicle-treated or 
scrambled RNA-transfected controls (∆∆CT method). 
 
Western Blotting 
SZ95 sebocytes were harvested in lysis buffer (20 mM Tris-HCl, pH 7.4, 5 mM EGTA, 
1 mM 4-(2-aminoethyl) benzensulfonyl fluoride, protease inhibitor cocktail diluted 
1:100, and PhosSTOP (1 tablet/10 ml) (all from Sigma-Aldrich), and the protein content 
was measured by a modified BCA protein assay (Pierce, Rockford, IL, USA). The 
samples were then subjected to sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. 10% Mini Protean TGX gels (Bio-Rad, Hercules, CA, USA) were 
loaded with equal (10 µg) amount of protein per lane. Samples were then transferred to 
nitrocellulose membranes, by using Trans-Blot® Turbo™ Nitrocellulose Transfer Packs 
and Trans-Blot Turbo™ System (both from Bio-Rad), and then probed overnight with 
rabbit-anti-human GPR119 specific primary antibodies (Novus Biologicals, LLC, 
Littleton, Co, USA; cat. No. NBP1-00857; in 1:500 dilution in 5% milk containing 
TBST [50 mM Tris, 150 mM NaCl, pH 7.5; 0.1 V/V% Tween 20, all from Sigma-
Aldrich]), rabbit-anti-human MAPK ERK1/2, as well as mouse-anti-human P-ERK1/2 
(both from Santa Cruz; 1:20,000 [ERK1/2] and 1:10,000 [P-ERK1/2] dilution in both 
cases in 5% milk containing TBST; cat. No. m3682 and m8159, respectively). As 
secondary antibodies, horseradish peroxidase-conjugated, goat anti rabbit and mouse 
IgG Fc segment (both from Bio-Rad; 1:10000 in 5% milk containing TBST; cat. No. 
170-6515 and 172-1011, respectively) were used, and the immunoreactive bands were 
visualized by a SuperSignal® West Pico Chemiluminescent Substrate enhanced 
chemiluminescence kit (Pierce) using a KODAK Gel Logic 1500 Imaging System 
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(Eastman Kodak Company, Kodak, Tokyo, Japan). To assess equal loading, membranes 
were re-probed with rabbit-anti-β-tubulin or rabbit-anti-β-actin antibodies (1:1000 
dilution in 5% milk containing TBST in both cases; rabbit-anti-β-tubulin: Novus 
Biologicals, LLC; cat. No. NB600-936; rabbit-anti-β-actin: Sigma-Aldrich; cat. No. 
A5060), and visualized as described above. Semiquantitative densitometric analysis of 
the signals was performed by using Fiji software (National Institutes of Health, 




In order to simultaneously assess the involvement of several kinase cascades in 
mediating the cellular effects of OEA, Proteome Profiler Human Phospho-Kinase Array 
Kit (cat. No. ARY003B; Bio-Techne R&D Systems) was used according to the 
manufacturer’s protocol. Briefly, SZ95 sebocytes were seeded to Petri dishes (d = 200 
mm; 10 million cells/15 ml culture medium/Petri dish). On the other day, sebocytes 
were treated by 50 µM OEA or vehicle for 20 min. Next, the samples were harvested by 
using the lysis buffer provided as part of the kit, and their protein content was 
determined as described in the western blot section. Equal protein amounts (933 µg in 
334 µl) were loaded, and the membranes were processed following the manufacturer’s 
protocol, except that the immunoreactive spots were visualized by a SuperSignal® West 
Femto Chemiluminescent Substrate enhanced chemiluminescence kit (Pierce) using a 
KODAK Gel Logic 1500 Imaging System (Eastman Kodak Company, Kodak). 
Semiquantitative densitometric analysis of the signals was performed by using Fiji 
software (National Institutes of Health). Means of the negative control spots on each 
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membrane were considered as background signal intensities, and were subtracted from 
the raw values. Background subtracted values were then normalized to the respective 





Primary human material was collected after obtaining written informed consent, 
adhering to Helsinki Declaration, and after obtaining Institutional Research Ethics 
Committee’s and Government Office for Hajdú-Bihar County’s permission (document 
IDs: IX-R-052/01396-2/2012, IF-12817/2015, IF-1647/2016, IF-778-5/2017, DE 
RKEB/IKEB 4988-2018). 
 
The immunohistochemical investigation of GPR119 was performed on 3 formalin fixed 
paraffin embedded, skin samples rich in sebaceous glands, all diagnosed as trichilemmal 
cyst in Gyula Kenézy University Hospital (University of Debrecen). Serial 4 µm thick 
sections were cut from paraffin blocks, and heat-induced antigen retrieval was 
performed. GPR119 epitopes were retrieved in 11 mM citrate buffer (pH 6) applied in 
pressure cooker for 2 min on full pressure. Endogenous peroxidase activity was blocked 
with 3% H2O2 for 10 minutes. Next, tissue sections were incubated at room temperature 
with rabbit primary antibodies recognizing human GPR119 (Novus Biologicals; cat. 
No. NBP1-00857) diluted in 1% bovine serum albumin (1:500; 60 min at room 
temperature; Sigma-Aldrich, St. Louis, MO, USA). Sections were then incubated with 
the EnVision FLEX Labeled polymer-HRP anti-rabbit and anti-mouse System (DAKO, 
Glostrup, Denmark) at room temperature for 30 min with 3,3’-diaminobenzidine (DAB) 
visualization techniques. Cell nuclei were counterstained with hematoxylin and tissue 
sections were finally mounted in permanent mounting medium (Histolab, Göteborg, 
Sweden). As positive control, human pancreas (Sakamoto et al. 2006) was labeled 
(Supplementary Figure S3). Since the manufacturer could not provide appropriate 
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blocking peptide, negative controls were obtained by omitting the primary antibody in 
all cases.  
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Assessment Of The Putative Expressional Alterations Of GPR119 In Acne 
Since the production of the above antibody has been discontinued, we optimized a 
second staining protocol with another antibody, which reproduced the expression 
pattern of the previously administered antibody (see Figure 3d and Figure 5a). 
Expression of GPR119 was assessed in skin samples of 6 acne-free patients (having 
pigmented nevi) as well as of 6 acne patients (relevant data of the donors can be found 
in Supplementary Table S1). Serial 4 µm thick sections were cut from paraffin blocks, 
and heat-induced antigen retrieval was performed. GPR119 epitopes were retrieved in 1 
mM EDTA buffer (pH 8) applied in microwave oven for 15 min on 700W. Endogenous 
peroxidase activity was blocked with 3% H2O2 for 10 minutes. Next, tissue sections 
were incubated at room temperature with rabbit primary antibodies recognizing human 
GPR119 (Abcam, Cambridge, UK; cat. No. ab75312) diluted in 1% bovine serum 
albumin (1:100; 60 min at room temperature; Sigma-Aldrich, St. Louis, MO, USA). 
Sections were then incubated with the EnVision FLEX Labeled polymer-HRP anti-
rabbit and anti-mouse System (DAKO, Glostrup, Denmark) at room temperature for 30 
min with 3,3’-diaminobenzidine (DAB) visualization techniques. Cell nuclei were 
counterstained with hematoxylin and tissue sections were finally mounted in permanent 
mounting medium (Histolab, Göteborg, Sweden). Since the manufacturer could not 
provide appropriate blocking peptide, negative controls were obtained by omitting the 
primary antibody in all cases. Visualization of the labeling was performed by using 
Olympus Fluorescent Microscope (UNICAM Magyarország Ltd., Budapest, Hungary). 
Original magnification was 200x in all cases. Semi-quantitative image analysis was 





Determination Of Cytokine Release (ELISA) 
Cells were treated as indicated for 3 hrs. Supernatants were collected, and the released 
amount of IL-6 and IL-8 cytokines was determined using OptEIA kits (BD Biosciences, 
San Diego, USA) according to the manufacturer’s protocol. 
 
Fluorescent Ca2+ Measurements 
Human SZ95 sebocytes were seeded in 96-well “black well/clear bottom” plates 
(Greiner Bio-One) at a density of 20,000 cells per well. The cells were washed once 
with 1% bovine serum albumin and 2.5 mM probenecid (both from Sigma-Aldrich) 
containing Hank’s solution (136.8 mM NaCl, 5.4 mM KCl, 0.34 mM Na2HPO4, 0.44 
mM KH2PO4, 0.81 mM MgSO4, 1.26 mM CaCl2, 5.56 mM glucose, 4.17 mM NaHCO3, 
pH 7.2, all from Sigma-Aldrich), and then were loaded with 1 µM Fluo-4 AM (Life 
Technologies Hungary Ltd.) dissolved in Hank’s solution (100 µl/well) at 37°C for 30 
min. The cells were then washed three times with Hank’s solution (100 µl/well). The 
plates were then placed into a FlexStation 3 multi-mode microplate reader (Molecular 
Devices) and alterations of the cytoplasmic Ca2+ concentration (reflected by changes in 
fluorescence; λEX: 490 nm, λEM: 520 nm) were monitored at room temperature following 
the application of OEA or vehicle. In order to probe reactivity and viability of the cells, 
at the end of each measurement, 0.2 mg/ml ATP was administered as a positive control. 
Data are presented as F/F0, where F0 is the average baseline fluorescence (i.e. before 





siRNA Transfection-Mediated Selective Gene Silencing Of GPR119 
Human SZ95 sebocytes were seeded in (d=35 mm) Petri dishes or in 96-well “black 
well/clear bottom” plates (Greiner Bio-One) in culture medium. On the other day, 
medium was changed, and the cells were transfected with siRNA oligonucleotides 
targeting human GPR119 (Stealth RNAi, assay IDs: HSS134803, HSS134804, and 
HSS134805; Life Technologies Hungary Ltd.) using Lipofectamine® RNAi MAX 
Transfection Reagent and serum-free Opti-MEM™ (both form ThermoFisher). For 
controls, siRNA Negative Control Duplexes with “medium” GC ratio (SCR, 
ThermoFisher) were employed. Silencing efficiency was monitored on post-transfection 
Days 2 and 3 at the mRNA (Q-PCR) and protein (Western blot) levels, respectively. In 
our preliminary experiments, we found that among the above three siRNA constructs, 
only one (HSS134805) was able to efficiently silence the expression of GPR119. In our 
hands, HSS134803 was not efficient, whereas the effect of HSS134804 could only be 
detected on post-transfection Day 2, but not on Day 3 (data not shown). Thus, in our 
subsequent experiments we used only HSS134805. 
 
Statistical Analysis 
Data were analyzed by IBM SPSS Statics software version 20 (IBM Armonk, North 
Castle, NY, USA), or GraphPad Prism 8.3.1 (549) (GraphPad Software , LLC, San 
Diego, CA, USA) using Student’s two-tailed, unpaired t-test (paired comparisons) or 
one-way ANOVA with Bonferroni’s post hoc test (multiple comparisons) and P<0.05 
values were regarded as significant differences. Graphs were plotted using Origin Pro 





As mentioned in the main text, the recently de-orphanized, “ECS-related” GPR119 
receptor has lately emerged as a promising therapeutic target in T2DM. Although the 
tested synthetic agonists have not passed yet phase II clinical trials (Yang et al. 2018), 
the promising animal data continuously encourage development and testing of novel 
GPR119 activators (Tyurenkov et al. 2017). Of great importance, however, both 
endogenous and synthetic agonists of GPR119 may exhibit biologically relevant 
signaling bias (Hassing et al. 2016), preferring one potential second messenger system 
over the others, and due to such bias, biological effects of the individual activators may 
be different. Thus, our data do not necessarily mean that all GPR119 agonists would 
promote sebaceous lipogenesis of human sebocytes. However, in case of those ones, 
which exhibit the highest similarities in their second messenger pathway profiles with 
the endogenous ligand OEA, risk of such adverse effects cannot be excluded (supposing 




Supplementary Figure S1 Up to 50 µM, OEA does not decrease viability of human 
SZ95 sebocytes 
MTT-assays. Viability of SZ95 sebocytes was monitored following 24- (a), and 48-hr 
(b) treatments. Results are expressed in the percentage of the vehicle control (100%, 
solid line) as mean±SEM of four independent determinations. Two additional 
experiments yielded similar results. OEA: oleoylethanolamide. 
 
Supplementary Figure S2 Up to 50 µM, OEA does not influence proliferation of 
human SZ95 sebocytes 
CyQUANT proliferation assay. SZ95 sebocytes were plated at low (2,000/well) initial 
cell count to enable rapid proliferation. Cell count was assessed following 48-hr 
treatments. Results are expressed in the percentage of the 24-hr vehicle control (100%, 
solid line) as mean±SEM of four independent determinations. Two additional 
experiments yielded similar results. OEA: oleoylethanolamide. 
 
Supplementary Figure S3 Positive control staining for GPR119 
(a-b) Immunohistochemistry of human pancreas was performed as described in the 
Supplementary Materials & Methods. Specific immunopositivity was visualized by 
3,3’-diaminobenzidine (DAB; brown color), whereas nuclei were counterstained by 
hematoxylin (blue color). Original magnification: 400x; scale bars: 50 µm. Negative 




Supplementary Figure S4 Higher non-cytotoxic concentrations of OEA further 
promote sebaceous lipogenesis; however, at 500 µM, OEA reduces viability of human 
sebocytes 
(a) Nile Red assay. Lipogenesis of SZ95 sebocytes was assessed following 24-hr 
treatments. Results are expressed in the percentage of the vehicle control (100%, solid 
line) as mean±SEM of twelve independent determinations. ** and *** mark significant 
(P<0.01 and 0.001, respectively) difference compared to the control group. n.s.: not 
significant, as indicated. (b) MTT-assay. Viability of SZ95 sebocytes was monitored 
following 24-hr treatments. Results are expressed in the percentage of the vehicle 
control (100%, solid line) as mean±SEM of twelve independent determinations. ** and 
*** mark significant (P<0.01 and 0.001, respectively) difference compared to the 
control group. n.s.: not significant, as indicated. OEA: oleoylethanolamide. 
 
Supplementary Figure S5 OEA does not influence Ca2+-homeostasis of human SZ95 
sebocytes 
Fluo-4 AM-based fluorescent Ca2+-measurement. Compounds (first OEA or vehicle, 
and then ATP as positive control) were applied as indicated by the respective arrows. 
Fluorescence (measured in relative fluorescence units) was normalized to the baseline. 
The graph shows a representative data set performed in octuplicate. OEA: 
oleoylethanolamide. 
 




(a) Expression of GPR119 in pre- and post-confluent sebocyte cultures (Figure 3c). (b-
c) Selective gene silencing of GPR119 (Figure 3f). Expression of GPR119 (b) and the 
loading control β-actin (c). Red rectangles indicate the relevant parts, which have been 
presented on Figure 3c and 3f. 
 
Supplementary Figure S7 Full, uncropped western blot membranes demonstrating 
ERK1/2 phosphorylation 
(a) Phospho-ERK1/2. (b) β-tubulin (loading control). (c) ERK1/2. (d) β-tubulin 
(loading control). Red rectangles indicate the relevant parts, which have been presented 





Supplementary Table S1 Relevant anamnestic data of the acne and acne-free patients, 
whose skin samples were used to assess GPR119 expression 
Acne-free patients (pigmented nevus) Acne patients 
Age Sex Region Age Sex Region 
25 male back 22 male back 
20 male back 37 male back 
19 male back 17 male back 
22 male back no data male back 
17 male back no data male back 
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